MyAverix Finance
SA · Healthcare
Sarepta Therapeutics Inc. (S1RP34)
Biotechnology
Sarepta Therapeutics Inc. (S1RP34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $10.96B, P/E ratio is 18.00, net margin is -32.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for S1RP34
Sarepta Therapeutics Inc. (S1RP34) — FAQ
What is Sarepta Therapeutics Inc.'s market cap?
Sarepta Therapeutics Inc. (S1RP34) has a reported market cap of $10.96B (data as of 2026-03-29).
What is S1RP34's P/E ratio?
The price-to-earnings (P/E) ratio for Sarepta Therapeutics Inc. (S1RP34) is 18.00 (data as of 2026-03-29).
Does Sarepta Therapeutics Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Sarepta Therapeutics Inc. (S1RP34). Check the MyAverix Finance app for the latest dividend data.
What sector is Sarepta Therapeutics Inc. in?
Sarepta Therapeutics Inc. (S1RP34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is S1RP34 listed on?
S1RP34 is listed on SA.
What is Sarepta Therapeutics Inc.'s net margin?
Sarepta Therapeutics Inc. (S1RP34) reports a net margin of -32.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.